Two Sigma Securities’s Galmed Pharmaceuticals GLMD Stock Holding History

Two Sigma Securities’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.13K	Sell	1,377 -119	-8%	-$593	﹤0.01%	1584
2026 Q1	$5.87K	Sell	1,496 -204	-12%	-$1.1K	﹤0.01%	1506
2025 Q4	$10.2K	Buy	+1,700	New	+$15.9K	﹤0.01%	1286
2025 Q2	–	Sell	-1,377	Closed	-$15.9K	–	1720
2025 Q1	$15.9K	Buy	+1,377	New	+$27.1K	﹤0.01%	1143
2024 Q3	–	Sell	-108	Closed	-$2.84K	–	3151
2024 Q2	$2.84K	Sell	108 -62	-36%	-$2.18K	﹤0.01%	2877
2024 Q1	$5.65K	Buy	+170	New	+$6.13K	﹤0.01%	2825
2022 Q4	–	Sell	-13	Closed	-$6K	–	2831
2022 Q3	$6K	Buy	+13	New	+$8.88K	﹤0.01%	2464
2020 Q2	–	Sell	-11	Closed	-$57K	–	1502
2020 Q1	$57K	Buy	+11	New	+$83.6K	﹤0.01%	1180

Other funds holding GLMD

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Securities's GLMD Position: Q2 2026 in Review

Two Sigma Securities reduced its Galmed Pharmaceuticals (GLMD) stake by 8% in Q2 2026, selling an estimated $593 and leaving 1,377 shares worth $6.13K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

Two Sigma Securities first reported a position in GLMD in Q1 2020 and has held it in 8 quarters since. The position peaked at $57K in Q1 2020. 11 funds tracked by Wall St. Rank hold GLMD as of Q2 2026.

Two Sigma Securities held 1,377 shares of Galmed Pharmaceuticals worth $6.13K as of Q2 2026.
Two Sigma Securities sold 119 Galmed Pharmaceuticals shares in Q2 2026, an estimated $593.
Galmed Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1584 holding.
Two Sigma Securities first reported a position in Galmed Pharmaceuticals in Q1 2020 and has held it in 8 quarters since.
Two Sigma Securities's Galmed Pharmaceuticals position peaked at $57K in Q1 2020.
11 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.